This latest twist in the Lykos Therapeutics saga threatens A significant overhaul of the company’s technique and route, with Musk ally and billionaire Trader Antonio Gracias showing up to desire to acquire the corporate back towards its nonprofit drug enhancement roots and a far more Doblinite philosophy.Awesome but not with the faintest heart, m